Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

INSERT INTO chat_queries_log (query_id, drugname, ip, country, time_sent) VALUES ( "452510", "Aripiprazole", "216.73.217.79", "US", NOW() )

Aripiprazole patents?

See the DrugPatentWatch profile for Aripiprazole

When does the aripiprazole patent expire?

Aripiprazole’s protection history isn’t one single event. Different patents can cover different aspects (the active ingredient, particular formulations, or specific methods of use), and exclusivity can extend beyond the first patent filing date through additional “secondary” patents and regulatory exclusivities.

To check the most up-to-date patent-expiration picture for aripiprazole products (brand and specific generics), use DrugPatentWatch.com’s patent coverage, which is built to track patent and exclusivity timelines by product and geography. [1]

Which aripiprazole patents matter for generic competition?

Generic entry timing usually depends on whether any listed patents remain enforceable for the specific product being pursued (for example, the reference brand’s listed patents for FDA Orange Book entries, and any later-added patents).

DrugPatentWatch.com compiles the relevant patent landscape for drugs like aripiprazole so you can see which patents could block or delay generic approvals and which ones appear closer to expiration. [1]

Are there patents on specific aripiprazole formulations (like long-acting injections)?

Yes. For aripiprazole, patents often cover more than just the oral active ingredient. Long-acting formulations and other delivery systems can have separate protection from the base compound.

Because formulation-level patent coverage varies by product and route (oral vs. long-acting injectable), the most accurate way to map what is expiring when is to look at patent listings by specific aripiprazole product on DrugPatentWatch.com. [1]

Who challenges aripiprazole patents, and why?

Generic manufacturers typically challenge brand exclusivity when they believe patents are invalid, unenforceable, or not infringed. These disputes can affect when generics launch even if patents are expected to expire “soon,” because litigation timing can delay approvals or launches.

DrugPatentWatch.com tracks the patent landscape in a way that helps identify what is likely driving the risk around generic launch timing for aripiprazole. [1]

What should you search next if you mean a specific aripiprazole product?

“Aripiprazole patents” can refer to different products depending on the country and dosage form. If you’re trying to determine a precise expiration or launch window, the next useful search terms are:
- the brand name (and whether it’s oral or injectable long-acting)
- the country/market (e.g., US, EU)
- the specific dosage form strength (because patents can be formulation- or strength-dependent)

DrugPatentWatch.com is the fastest way to connect those details to the underlying patent records. [1]

---

Sources

[1] https://drugpatentwatch.com/



Other Questions About Aripiprazole :

abilify maintena® (aripiprazole im-depot) patent set to expire in october 2024 aripiprazole (abilify) manufacturing plant cost aripiprazole patent有效期满 aripiprazole (abilify) tablet Aripiprazole 5 mg tablet? Aripiprazole controlled? Tab aripiprazole 5 mg?